title: Antineutrophil cytoplasmatic antibody positive systemic vasculitis in a patient treated with propylthiouracil.
abstract: The development of antineutrophil cytoplasmatic antibody (ANCA) during therapy with propylthiouracil (PTU) is not uncommon but occasionally has clinical significance. Risk factors associated with the development of ANCA associated systemic vasculitis when taking PTU have been described. We report and discuss a case with PTU-induced ANCA vasculitis with severe systemic manifestations.
authors.forename: Sara Vieira
authors.initials: SV
authors.lastname: Silva
authors.forename: João Pedro
authors.initials: JP
authors.lastname: Ferreira
authors.forename: Sandrine
authors.initials: S
authors.lastname: Carvalho
authors.forename: Filipa
authors.initials: F
authors.lastname: Seabra
authors.forename: António
authors.initials: A
authors.lastname: Marinho
mesh_terms: D000368:Aged; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D011441:Propylthiouracil / Q000009:adverse effects*
chemical_list: D011441:Propylthiouracil